News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Sandisk trading at $1,543 after recovery, prompting a tactical long setup with entry near $1,540.
  • Recommended Sandisk stop $1,450 and target $1,850 over a roughly 45‑trading‑day horizon.
  • GXO sits in the low $45s, flagged as a defined‑risk long with entry near $45.87.
  • GXO stop recommended at $43.00 and target set at $60.00 over about 45 trading days.
  • Lionsgate pitched as a library play with entry $6.00, stop $4.50 and $9.00 target over 180 trading days.

Latest Articles

Microsoft Shares Rise as Cloud, AI Milestones Drive Post-Earnings Momentum

Microsoft Shares Rise as Cloud, AI Milestones Drive Post-Earnings Momentum

Microsoft shares climbed in pre-open trading after a fiscal 2026 fourth-quarter report that beat expectations. The company reported $90 billion in revenue, a 18% year-over-year gain, with Azure revenue up 43% and crossing $100 billion in annual revenue. A rapidly expanding commercial order backlog and upgraded analyst views have bolstered investor …

Latigo Biotherapeutics Files to Raise Up to $288 Million in IPO

Latigo Biotherapeutics Files to Raise Up to $288 Million in IPO

Latigo Biotherapeutics Inc. has filed to raise up to $288 million in an initial public offering, proposing 16 million shares priced between $16 and $18. The clinical-stage company, which develops non-opioid pain treatments and is backed by Blue Owl Capital Inc., reported recent operating losses, a mid-2027 target for Phase 3 results and held $54.8 …

S&P 500 Monthly Review: Record Close Amid Rotation and Elevated Volatility

S&P 500 Monthly Review: Record Close Amid Rotation and Elevated Volatility

The S&P 500 closed at a record 7,489.72 on Aug 3, 2026, delivering a rolling one-year return of 20.1%. The advance followed a volatile sequence that began in early 2025, featuring a sharp spring selloff, heavy month-to-month swings, a rebound led by mega-cap technology, and intermittent rotation into cyclical sectors. Persistent speculative caution…

Nexera Enters into Letter of Intent for Exclusive Distribution Rights to Darknet Intelligence Platform for Data Centers

Nexera Enters into Letter of Intent for Exclusive Distribution Rights to Darknet Intelligence Platform for Data Centers

Nexera Technologies Ltd announced a letter of intent with Nebo Holdings Limited to become the exclusive worldwide reseller and distributor of Nebo's Preempt OSINT darknet intelligence software, targeting operators of data centers with threat detection services. The agreement, pending a technical proof of concept and due diligence, aims to expand Ne…

Boris Nadezhdin Says He Has Left Russia, Posts Video from Paris

Boris Nadezhdin Says He Has Left Russia, Posts Video from Paris

Boris Nadezhdin, a 63-year-old former liberal lawmaker and outspoken critic of Russia's war in Ukraine, said he has left Russia and is currently abroad. In a short video posted on Telegram from the Eiffel Tower in Paris, he said he was "alive and free" and would outline his next steps later. His exit follows his inclusion on Russia's "foreign agent…

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Helus Pharma announces the appointment of Michael Halstead as CEO to lead the company through critical late-stage clinical development and commercialization phases. Halstead brings 25 years of experience from Intra-Cellular Therapies, including a successful track record in drug development, launch, and commercialization. The company is advancing HL…

Genprex Shares Slide After Early Rally on Roche Diagnostics Collaboration

Genprex Shares Slide After Early Rally on Roche Diagnostics Collaboration

Genprex stock tumbled 12.4% in pre-market trading after an initial uptick following a newly announced collaboration with Roche Diagnostics to validate TROP2 and PTEN as biomarkers for non-small cell lung cancer trials. The deal briefly lifted the micro-cap's shares by about 3% before selling pressure erased gains. Broader U.S. equity indices were p…

Curium Announces Definitive Agreement to Merge with Lantheus

Curium Announces Definitive Agreement to Merge with Lantheus

Curium US Holdings is acquiring Lantheus Holdings in an $8 billion deal that will consolidate complementary radiopharmaceutical portfolios and global manufacturing and commercial platforms. The transaction offers Lantheus shareholders $102.50 per share in cash at closing plus up to $12.00 per share in contingent value rights tied to commercial mile…

Navigator Gas Announces Signing of $121.8 Million Financing for Two Newbuild Ammonia Carriers in Navigator Amon Joint Venture

Navigator Gas Announces Signing of $121.8 Million Financing for Two Newbuild Ammonia Carriers in Navigator Amon Joint Venture

Navigator Holdings Ltd. announced the signing of a $121.8 million senior secured loan facility to finance two newbuild ammonia-fueled liquefied ammonia carriers currently under construction in China. The financing supports the company's ammonia growth strategy, enabling delivery of the vessels in 2028 with a six-year post-delivery tenor and competi…

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

ARS Pharmaceuticals, a biopharmaceutical company focused on treatments for allergic reactions and anaphylaxis, announced a conference call and webcast on August 13, 2026, to outline updated strategic priorities and report their Q2 2026 financial results. The company is commercially offering neffy®, an epinephrine nasal spray approved for emergency …

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma Ltd. appoints Dr. Faisal Mehmud, Chief Medical Officer and Co-Chairman of Antev Limited, as CEO of its UK subsidiary effective August 30, 2026. This leadership move aims to unify scientific, clinical, regulatory, and operational efforts as the company advances development of Teverelix®, targeting advanced prostate cancer, urinary ret…

Hydrofarm Completes Sale of Aurora Peat Products and Launches Project Agility to Scale Its Logistics Services Platform

Hydrofarm Completes Sale of Aurora Peat Products and Launches Project Agility to Scale Its Logistics Services Platform

Hydrofarm Holdings Group, Inc. has completed the sale of its subsidiary Aurora Peat Products to Raven Holdings LLC for $16 million, applying proceeds to reduce debt and simplify operations. The company will maintain a supply agreement with Aurora Peat and plans to focus on scaling its logistics services platform through a new initiative named Proje…

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

Zevra Therapeutics announced the publication of a four-year longitudinal real-world study assessing its FDA-approved drug MIPLYFFA® (arimoclomol) in treating Niemann-Pick disease type C (NPC). The study, covering 109 U.S. patients including adults, showed stable disease severity scores and confirmed the drug's known safety profile. This data streng…

SOLOWIN HOLDINGS’ (NASDAQ: AXG) Subsidiary AX Coin Bahrain Receives Sharia Certification for AXBHD Stablecoin

SOLOWIN HOLDINGS’ (NASDAQ: AXG) Subsidiary AX Coin Bahrain Receives Sharia Certification for AXBHD Stablecoin

Solowin Holdings' subsidiary AX Coin Bahrain has achieved a significant milestone by obtaining formal Sharia certification for its AXBHD stablecoin. This certification, conducted by the Shariyah Review Bureau licensed by the Central Bank of Bahrain, marks AXBHD as the first central bank-regulated stablecoin to receive such recognition. The certific…

South African opposition party takes legal fight over expropriation law to court

South African opposition party takes legal fight over expropriation law to court

South Africa's Democratic Alliance has filed a court challenge to the Expropriation Act, a law allowing the state to seize land in the public interest and cited by U.S. President Donald Trump when he cut off aid last year. The move has increased tensions within the governing coalition with the African National Congress as the country approaches mun…